Wells Fargo’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Wells Fargo's RGEN Position: Q2 2026 in Review
Wells Fargo reduced its Repligen (RGEN) stake by 6.1% in Q2 2026, selling an estimated $269K and leaving 33,715 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.
Wells Fargo first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $258M in Q3 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Wells Fargo held 33,715 shares of Repligen worth $4.6M as of Q2 2026.
- Wells Fargo sold 2,190 Repligen shares in Q2 2026, an estimated $269K.
- Repligen made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2920 holding.
- Wells Fargo first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Repligen position peaked at $258M in Q3 2021.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.